The Supreme Court on Friday agreed to review an appeals courts decision that generic drug manufacturers can face lawsuits over alleged problems in the design of drugs, regardless of federal protections against design-defect claims.
By Alanna Byrne|December 03, 2012
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.